Related references
Note: Only part of the references are listed.Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications
William E. Rosenfeld et al.
EPILEPSIA (2021)
Safety and efficacy of adjunctive lacosamide in Chinese and Japanese adults with epilepsy and focal seizures: A long-term, open-label extension of a randomized, controlled trial
Yushi Inoue et al.
EPILEPSY RESEARCH (2021)
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial
Gregory L. Krauss et al.
LANCET NEUROLOGY (2020)
Clinical risk factors in SUDEP A nationwide population-based case-control study
Olafur Sveinsson et al.
NEUROLOGY (2020)
Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study
Michael R. Sperling et al.
EPILEPSIA (2020)
Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures
Steve S. Chung et al.
NEUROLOGY (2020)
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multi-centre, double-blind, randomised, placebo-controlled, dose-response trial (vol 19, pg 38, 2020)
G. L. Krauss et al.
LANCET NEUROLOGY (2020)
Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307
Gregory L. Krauss et al.
EPILEPSIA (2018)
The management of epilepsy in children and adults
Piero Perucca et al.
MEDICAL JOURNAL OF AUSTRALIA (2018)
Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs A 30-Year Longitudinal Cohort Study
Zhibin Chen et al.
JAMA NEUROLOGY (2018)
Active Epilepsy and Seizure Control in Adults - United States, 2013 and 2015
Niu Tian et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
The burden of premature mortality of epilepsy in high-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy
David J. Thurman et al.
EPILEPSIA (2017)
ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology
Ingrid E. Scheffer et al.
EPILEPSIA (2017)
Drug development for refractory epilepsy: The past 25 years and beyond
Ambica Golyala et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)
Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures
Manuel Toledo et al.
EPILEPSIA (2016)
A reappraisal of mortality after epilepsy surgery
Michael R. Sperling et al.
NEUROLOGY (2016)
The consequences of refractory epilepsy and its treatment
Kenneth D. Laxer et al.
EPILEPSY & BEHAVIOR (2014)
Epilepsy-related clinical characteristics and mortality A systematic review and meta-analysis
Olli Nevalainen et al.
NEUROLOGY (2014)
Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: Results from a phase III open-label extension trial
Aatif Husain et al.
EPILEPSIA (2012)
Injuries due to seizures in persons with epilepsy - A population-based study
ND Lawn et al.
NEUROLOGY (2004)
Measuring the efficacy of antiepileptic drugs
R Mohanraj et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2003)
Share Paper
